Results 31 to 40 of about 218 (97)

BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185 [PDF]

open access: yesPharmaceuticals
The healing issue is a central, not completely understood, problem in pharmacology, approached by many concepts. One of the most well-known is Robert’s and Szabo’s concept of cytoprotection, which holds innate cell (epithelial (Robert), endothelial ...
Predrag Sikiric   +15 more
doaj   +2 more sources

Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System—Triple NO-Agent Approach in Rats [PDF]

open access: yesPharmaceuticals
Background/Objectives: This 7-day rat tracheocutaneous fistula study considered the not-studied issues of tracheocutaneous fistula course, wound healing, and fistula in the NO-system relations.
Goran Madzarac   +22 more
doaj   +2 more sources

Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats [PDF]

open access: yesFrontiers in Pharmacology, 2022
Marijan Tepes   +26 more
doaj   +2 more sources

Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics [PDF]

open access: yesPharmaceuticals
This review presents an innovative and timely exploration of how cytoprotection can serve as a cohesive therapeutic approach by which to address the hemorrhage–thrombosis paradox.
Predrag Sikiric   +23 more
doaj   +2 more sources

Challenge of Corneal Ulcer Healing: A Novel Conceptual Framework, the “Triad” of Corneal Ulcer Healing/Corneal Neovascularization/Intraocular Pressure, and Avascular Tendon Healing, for Evaluation of Corneal Ulcer Therapy, Therapy of Neovascularization, Glaucoma Therapy, and Pentadecapeptide BPC 157 Efficacy [PDF]

open access: yesPharmaceuticals
To better address the challenge of corneal ulcer healing, with already available standard agents, and those recently introduced, such as stable gastric pentadecapeptide BPC 157, we introduced a novel conceptual framework—the “triad” of corneal ulcer ...
Sanja Masnec   +18 more
doaj   +2 more sources

Effect of Pentadecapeptide BPC 157 on Hypercalcaemia in Rats

open access: yesLiječnički vjesnik, 2023
Isolated from gastric juice stable pentadecapeptide BPC 157 has already shown cytoprotective and organoprotective properties. Beneficial effects of BPC 157 on various organic systems such as cardiovascular, digestive, skeletomuscular system have already ...
Matej Lacković   +2 more
doaj   +1 more source

Histological aspects of Therapeutic effects of Stable gastric pentadecapeptide BPC 157 on stomach perforation

open access: yesLiječnički vjesnik, 2023
We focused on histological aspects of the cytoprotective effects of Stable gastric pentadecapeptide BPC 157 after stomach perforation in rats was performed.
Petra Horvat   +2 more
doaj   +1 more source

Stable gastric pentadecapeptide BPC 157

open access: yesJournal of physiology and pharmacology, 2009
Considering peptidergic drugs, many cytokines, enzymes, clotting factors registered for the use as therapeutic agents in specific conditions, they are mainly given by injection, only occasionally by other routes. Also, to ascertain delivery and activity, they use different carriers, peptide+carrier complex may provide significant methodology/activity ...
Sikirić, Predrag   +3 more
  +9 more sources

Stable Gastric Pentadecapeptide BPC 157 Macroscopic Effect on Haematoma and Swelling in Spinal Cord Injured Rats

open access: yesLiječnički vjesnik, 2023
The aim of this study is to investigate the effect of stable gastric pentadecapeptide BPC 157 effect on counteracting haematoma and swelling caused by spinal cord injury.
Luka Ćorić   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy